How did IDEXX Labs' revenue and expenses trend in Q4 2024?

IDEXX Laboratories exhibited robust revenue and a healthy profit margin in Q4 2024, with total revenue amounting to $954.29 million and a net income of $216.15 million: 1. **Revenue Trend**: The company's revenue was well-distributed across various business segments, with the Companion Animal Group contributing the most, followed by Water quality products and Other business segments. The consistent revenue across segments indicates a diversified and stable revenue model. 2. **Expense Management**: IDEXX Labs managed its operating expenses effectively, with figures for R&D, Selling, General, and Administrative (SG&A) expenses amounting to $57.73 million, $251.25 million, respectively. The company's ability to control these expenses suggests a strong operational efficiency. 3. **Profitability**: The net income of $216.15 million reflects the company's profitability for the period, indicating that IDEXX Labs is not only generating substantial revenue but also managing its costs to maintain a healthy profit margin. |code|Ticker|Name|Date|Business Composition|Revenue By Business|market_code| |---|---|---|---|---|---|---| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Other|1.6288E7|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Other|1.2181E7|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Other|7782000|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Other|3534000|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Water quality products|4.3071E7|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Companion Animal Group|8.89285E8|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Livestock, Poultry and Dairy|2.8205E7|185| |IDXX|IDXX.O|IDEXX Laboratories|20240101-2024|Other|3534000|185| |code|Ticker|Name|Date|Net Income YoY|Net Income|market_code| |---|---|---|---|---|---|---| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q1|10.05587375148327|2.35579E8|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q2|-9.337483722506645|2.03298E8|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q3|9.711116660619796|2.32841E8|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q4|11.118593879324083|2.16149E8|185| |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q1|7.098461999900022|9.64095E8|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q2|6.352913747973251|1.003578E9|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q3|6.555350087982113|9.75543E8|185| |IDXX|IDXX.O|IDEXX Laboratories|2024 Q4|5.843715790022416|9.54288E8|185| |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|Selling, General, and Administrative Expenses YoY|market_code| |---|---|---|---|---|---|---| |IDXX|IDXX.O|IDEXX Laboratories|20240331|2.41477E8|10.817558110185631|185| |IDXX|IDXX.O|IDEXX Laboratories|20240630|2.99908E8|30.280928406045156|185| |IDXX|IDXX.O|IDEXX Laboratories|20240930|2.38168E8|5.978676823950305|185| |IDXX|IDXX.O|IDEXX Laboratories|20241231|2.51245E8|9.688587357511144|185|